CSMYF (COSMOS Pharmaceutical) Owner Earnings per Share (TTM): 0.00 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CSMYF COSMOS Pharmaceutical Corp CSMYF
93 GF Score
Price $37.06
GF Value $50.48
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is COSMOS Pharmaceutical Owner Earnings per Share (TTM)?

COSMOS Pharmaceutical CSMYF 93 Owner Earnings per Share (TTM) is 0.00 as of May. 2026. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 310 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 322580.32% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

COSMOS Pharmaceutical does not have enough data to calculate Owner Earnings per Share (TTM), so as Price-to-Owner-Earnings ratio.


The historical rank and industry rank for COSMOS Pharmaceutical's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of COSMOS Pharmaceutical was 237.81. The lowest was 86.50. And the median was 104.67.


CSMYF's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.745
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

COSMOS Pharmaceutical's Earnings per Share (Diluted) for the three months ended in Feb. 2026 was $0.66. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was $2.63. It's PE Ratio (TTM) ratio for today is 14.11.

COSMOS Pharmaceutical's EPS without NRI for the three months ended in Feb. 2026 was $0.66. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 was $2.65. It's PE Ratio without NRI ratio for today is 13.99.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


COSMOS Pharmaceutical Owner Earnings per Share (TTM) Related Terms


COSMOS Pharmaceutical Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for COSMOS Pharmaceutical's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

COSMOS Pharmaceutical Owner Earnings per Share (TTM) Chart

COSMOS Pharmaceutical Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COSMOS Pharmaceutical Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COSMOS Pharmaceutical Owner Earnings per Share (TTM) Competitor Comparison

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical Price-to-Owner-Earnings vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Price-to-Owner-Earnings falls into.


CSMYF
93GF Score
COSMOS Pharmaceutical Corp CSMYF
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

COSMOS Pharmaceutical Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

COSMOS Pharmaceutical does not have enough data to calculate Owner Earnings per Share (TTM). Please check Wal-Mart Stores Inc, as your reference.

What does a Owner Earnings per Share (TTM) of 0.00 mean?
COSMOS Pharmaceutical (CSMYF) has a Owner Earnings per Share (TTM) of 0.00 as of May. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on COSMOS Pharmaceutical. Over the past decade, COSMOS Pharmaceutical's Owner Earnings per Share (TTM) has ranged from 86.50 to 237.81. According to the industry distribution chart, COSMOS Pharmaceutical ranks #999999 out of 310 companies in the Healthcare Providers & Services industry.
Is COSMOS Pharmaceutical's Owner Earnings per Share (TTM) too high?
COSMOS Pharmaceutical's current Owner Earnings per Share (TTM) is 0.00. Over the past 10 years, this metric has ranged from a low of 86.50 to a high of 237.81. Based on the distribution chart, COSMOS Pharmaceutical ranks #999999 out of 310 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Owner Earnings per Share (TTM) compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #999999 out of 310 companies for Owner Earnings per Share (TTM). This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 17.75. Historically, COSMOS Pharmaceutical's own Owner Earnings per Share (TTM) has ranged from 86.50 to 237.81 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Healthcare Providers & Services company?
The median Owner Earnings per Share (TTM) among Healthcare Providers & Services companies is 17.75, based on 310 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on COSMOS Pharmaceutical. For the Healthcare Providers & Services industry, the median Owner Earnings per Share (TTM) is 17.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Owner Earnings per Share (TTM) is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Owner Earnings per Share (TTM) is 0.00. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Owner Earnings per Share (TTM) is 0.00 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?

Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued. The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48. GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.

Key valuation signals for CSMYF:

  • Owner Earnings per Share (TTM): 0.00
  • GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


COSMOS Pharmaceutical Business Description

Other Exchanges 3349:Japan
Address 10-1 Hakataeki Higashi 2-chome, 4th floor, JR Hakata Station East NS Building S, Hakata-ku, Fukuoka Prefecture, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score

Get the complete analysis for CSMYF

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.06
Price
$50.48
GF Value